We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

2413:TSEM3, Inc. Analysis

Data as of 2026-03-11 - not real-time

¥1,620.50

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

The stock is trading at ¥1,620.5, which sits below its 20‑day (¥1,628.98), 50‑day (¥1,857.62) and 200‑day (¥2,084.28) simple moving averages, signalling a short‑term bearish bias. Nevertheless, the MACD line has crossed above its signal line, producing a positive histogram of ¥18.73 and a “bullish” label, hinting at emerging upward momentum. The 14‑day RSI sits at 40.3, comfortably above oversold territory but still leaving room for upside. Technical support is identified near ¥1,495 and resistance near ¥1,764, framing the current price corridor. Volatility is elevated at roughly 47% over the past 30 days, while the beta of ~0.38 indicates the stock moves less than the broader market.
On the fundamentals side, revenue grew 15.9% year‑over‑year to ¥343.8 bn, with a healthy gross margin of 50.4% and operating margin of 27.8%. Net profit margin stands at 14.4% and ROE at 12.5%, underscoring efficient earnings generation. The balance sheet is strong, with cash of ¥144.3 bn dwarfing debt of ¥33.8 bn, resulting in a net‑cash position that mitigates financial risk. The trailing P/E of 24.45 is slightly below the industry average of 25.15, and the forward P/E of 22.62 suggests modest undervaluation. A dividend yield of 1.27% is supported by a 31% payout ratio, indicating sustainability. Analyst consensus projects a median price target of ¥2,590, implying upside of roughly 56%, and the market sentiment index reads “Extreme Greed” at 78.16.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Price below key moving averages suggests a potential bounce
  • Bullish MACD crossover indicates emerging momentum
  • Support level at ¥1,495 provides downside protection

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • 15.9% revenue growth and strong margins
  • Undervalued relative to industry P/E
  • Robust cash position and sustainable dividend

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Long‑term upside potential of ~56% per analyst targets
  • Low beta and high cash buffer reduce systemic risk
  • Healthcare information services benefit from aging demographics

Key Metrics & Analysis

Financial Health

Revenue Growth15.90%
Profit Margin14.42%
P/E Ratio24.4
ROE12.47%
ROA7.61%
Debt/Equity7.44
P/B Ratio2.6
Industry P/E25.2

Technical Analysis

TrendBearish
RSI40.3
Support¥1,495.00
Resistance¥1,764.00
MA 20¥1,628.98
MA 50¥1,857.62
MA 200¥2,084.28
MACDBullish
VolumeStable
Fear & Greed Index78.16

Valuation

Target Price¥2,533.57
Upside/Downside56.35%
GradeUndervalued
TypeBlend
Dividend Yield1.27%

Risk Assessment

Beta0.38
Volatility46.98%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.